5-Amino-3-(3-methoxyphenyl)isoxazole

Catalog No.: 
ACSRQL487
CAS No.: 
119162-46-8
Molecular Formula: 
C10H10N2O2
Molecular Weight: 
190.20
5-Amino-3-(3-methoxyphenyl)isoxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$65.00InquiryInquiry
10g97%$128.00InquiryInquiry
25g97%$274.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Amino-3-(3-methoxyphenyl)isoxazole
IUPAC Name3-(3-methoxyphenyl)isoxazol-5-amine
MDL No.MFCD07383035
Molecular FormulaC10H10N2O2
Molecular Weight190.20
SMILESNC1=CC(C2=CC=CC(OC)=C2)=NO1
InChI KeyGFZSBBXGHNWHSF-UHFFFAOYSA-N
SynonymARGIPRESSINACETATE | 3-(3-methoxyphenyl)-1,2-oxazol-5-amine | DTXSID80405392 | EN300-231552 | STK348648 | SY012485 | 3-(3-Methoxyphenyl)isoxazol-5-amine | SCHEMBL22653460 | J-510617 | 3-(3-Methoxy-phenyl)-isoxazol-5-ylamine | 3-(3-methoxy-phenyl)-isoxazol
CAS No.119162-46-8
PubChem CID4669099

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACSRQL487 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSRQL487 route product structure diagram
    ACSRQL487119162-46-8In Stock
Inquiry

2. ACSRQL487 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSRQL487 route product structure diagram
    ACSRQL487119162-46-8In Stock
Inquiry

3. ACSRQL487 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSRQL487 route product structure diagram
    ACSRQL487119162-46-8In Stock
Inquiry

Comments (0)